Senior Partner


+65 6885 3636

Highly regarded


Bar admissions:

England & Wales



Practice areas:


Corporate/Mergers & Acquisitions specialist, encompassing domestic, regional and cross-border private and public takeovers and mergers and acquisitions, pre-transaction M&A strategies, corporate commercial work, corporate finance, corporate restructurings (solvent and insolvent), securities law, private equity and general corporate law. Ranked in Asialaw and Chambers. Independent Director, Hyphens Pharma International.

  • Advised FMC Corporation on the Singapore corporate aspects of the two transformative global transactions with DuPont involving 45 countries and a consideration of US$1.6 billion.
  • Acting for Yinson Eden Pte. Ltd., an indirect wholly-owned subsidiary of Yinson Holdings Berhad,  in its proposed acquisition of up to US$916 million of Ezion Holdings Limited’s existing bank loan which may result in Yinson Eden holding over 85% of the enlarged share capital of Ezion.
  • Advised Standard Chartered Private Equity (Singapore) Pte. Ltd. in its joint venture with certain majority shareholders of SGX-ST-listed Tat Hong Holdings Ltd to privatiseTat Hong Holdings Ltd.
  • Acted for GlobalFoundries Singapore Pte. Ltd. in the sale of its FAB 3E in Singapore to Vanguard International Semiconductor Corporation for US$236 million.

  • M&A
  • Private equity

  • Financial services
  • Food and beverage
  • Healthcare
  • Industrials
  • Tech and telecoms

  • Singapore
  • Malaysia
  • England and Wales

  • The Law Society of Singapore
  • Singapore Academy of Law

  • LLB (Hons), National University of Singapore, (1989)
  • LLM, National University of Singapore, (1995)